Pinnacle West Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$622K Hold
7,955
0.43% 65
2026
Q1
$689K Sell
7,955
-100
-1% -$9.58K 0.47% 59
2025
Q4
$774K Sell
8,055
-100
-1% -$9.71K 0.5% 57
2025
Q3
$777K Buy
8,155
+80
+1% +$7.35K 0.5% 55
2025
Q2
$704K Sell
8,075
-75
-0.9% -$6.36K 0.49% 59
2025
Q1
$732K Buy
8,150
+115
+1% +$10.3K 0.53% 59
2024
Q4
$642K Buy
8,035
+25
+0.3% +$2.16K 0.46% 62
2024
Q3
$721K Buy
8,010
+275
+4% +$23.1K 0.52% 58
2024
Q2
$609K Hold
7,735
0.47% 61
2024
Q1
$674K Buy
7,735
+35
+0.5% +$2.99K 0.54% 57
2023
Q4
$634K Buy
7,700
+400
+5% +$30.5K 0.54% 58
2023
Q3
$572K Buy
7,300
+1,225
+20% +$103K 0.56% 57
2023
Q2
$535K Buy
6,075
+50
+0.8% +$4.3K 0.52% 63
2023
Q1
$486K Buy
+6,025
New +$491K 0.51% 66

Other funds holding MDT

Pinnacle West Asset Management's MDT Position: Q2 2026 in Review

Pinnacle West Asset Management held its Medtronic (MDT) position steady in Q2 2026 at 7,955 shares worth $622K. The position accounts for 0.43% of the portfolio, ranked #65.

Pinnacle West Asset Management first reported a position in MDT in Q1 2023 and has held it in 14 quarters since. The position peaked at $777K in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Pinnacle West Asset Management held 7,955 shares of Medtronic worth $622K as of Q2 2026.
  • Pinnacle West Asset Management left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.43% of Pinnacle West Asset Management's portfolio in Q2 2026, its #65 holding.
  • Pinnacle West Asset Management first reported a position in Medtronic in Q1 2023 and has held it in 14 quarters since.
  • Pinnacle West Asset Management's Medtronic position peaked at $777K in Q3 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Pinnacle West Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.